Advertisement
Advertisement
U.S. Markets close in 5 hrs 45 mins
Advertisement
Advertisement
Advertisement
Advertisement

cbdMD, Inc. (YCBD)

NYSE American - Nasdaq Real Time Price. Currency in USD
0.2599-0.0101 (-3.74%)
As of 10:15AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2700
Open0.2647
Bid0.2551 x 1100
Ask0.2600 x 800
Day's Range0.2550 - 0.2688
52 Week Range0.2000 - 1.5730
Volume17,351
Avg. Volume235,703
Market Cap15.145M
Beta (5Y Monthly)2.01
PE Ratio (TTM)N/A
EPS (TTM)-0.2010
Earnings DateDec 14, 2022 - Dec 19, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    cbdMD Successfully Launches Into a Growing Japanese Market

    Charlotte, North Carolina--(Newsfile Corp. - November 29, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized health and wellness companies, has announced it has completed a successful initial launch into the emerging Japanese market. According to Brightfield Group, a leading CBD research firm, Japan is the largest CBD market by revenue in the Asia Pacific and Middle East region. cbdMD believes ...

  • Newsfile

    cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits

    Initial Results from the First of Its Kind Clinical Study Demonstrate cbdMD's Proprietary Broad Spectrum Hemp Extract Reduces Pain in Healthy Adults. Charlotte, North Carolina--(Newsfile Corp. - November 17, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the first results from its recently concluded human clinical trial conducted at the University of South Carolina. These studies

  • Newsfile

    cbdMD to Present at ThinkEquity Conference on October 26, 2022, in New York City

    Charlotte, North Carolina--(Newsfile Corp. - October 25, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted, and widely recognized CBD companies, announced today that the Company will present at the ThinkEquity Conference on Wednesday, October 26, 2022, at 12:30pm ET at the Mandarin Oriental Hotel in New York City. cbdMD's President Kevin MacDermott and Chief Financial Officer Ronan Kennedy will be conducting one-on-one meetings through

Advertisement
Advertisement